By Rupali Mukherjee MUMBAI: Vaccines are back in favour. After being junked by pharma biggies some years back, now almost every drug major is investing in vaccines by acquiring or building on fresh capacities (organic or inorganic route). The evidence lies in pharma biggie Pfizer acquiring Wyeth and domestic major Shantha Biotech being snapped up […]